bimatoprost


Also found in: Wikipedia.

bimatoprost

 [bĭ-mat´o-prost]
a synthetic prostaglandin analogue that acts as an ocular hypotensive; applied topically to the conjunctiva in the treatment of open-angle glaucoma and ocular hypertension.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

bimatoprost

A synthetic PROSTAGLANDIN drug used as eye drops to control raised intraocular pressure in GLAUCOMA. A brand name is Lumigan.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005

prostaglandin analogues 

Drugs used in the treatment of open-angle glaucoma or ocular hypertension. At specific dosages they lower the intraocular pressure (IOP), supposedly by increasing the outflow of aqueous humour via the uveoscleral pathway. Common agents include latanoprost, travoprost, bimatoprost (a synthetic prostamide structurally related to prostaglandin) and unoprostone isopropyl. Bimatoprost reduces IOP by increasing the uveoscleral outflow as well as the trabecular outflow.
Millodot: Dictionary of Optometry and Visual Science, 7th edition. © 2009 Butterworth-Heinemann
Mentioned in ?
References in periodicals archive ?
A two-year comparative study by Cohen et al 2004 showed mean reduction of 7.8 mmHg with Bimatoprost and 4.6 mmHg with Timolol.(14)
A comparative study on the safety and efficacy of topical bimatoprost with timolol maleate in glaucoma patients
(2) Bimatoprost ise prostamid analogu olup, etkisini humor akozun hem uveoskleral hem de trabekuler agdan disa akimini artirarak gostermektedir.
Comparison of the efficacy of latanoprost, bimatoprost, and travoprost in patients with primary open-angle glaucoma and ocular hypertension/Primer acik acili glokomlu ve okuler hipertansiyonlu hastalarda latanoprost, bimatoprost ve travoprostun etkinliginin karsilastirilmasi
Latisse - the "Botox for eyelashes", which has been developed from Bimatoprost - a medication used to treat eye disorders including glaucoma, is also being used by many actresses, including 'Man Men' star Christina Hendricks, Claire Danes and Brooke Shields.
Botox for eyelashes to make mascara history
The product works by making lash growth possible via bimatoprost, its active ingredient.
Some cosmetic alternatives to professional procedures: using terminology and technologies borrowed from cosmetic procedures, skin care brands have raised the bar in terms of product claims. Here's a look at the key aesthetic medicine trends that have impacted the next generation of cosmetic and skin care products
Allergan received approval from the FDA for Lumigan (bimatoprost ophthalmic solution) 0.01% as a first-line therapy for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Boehringer's Pradaxa approved by FDA: Curis, Genentech begin Phase II skin cancer trial
Prostaglandin analogues in the market include: latanoprost, bimatoprost, and travoprost.
Herpetic keratitis in a patient who used two different prostaglandin analogue ophthalmic solutions: a case report
The Food and Drug Administration seized more than 12,000 tubes of a product claiming to increase eyelash growth because it was found to contain bimatoprost the active ingredient in a prescription glaucoma solution--that could potentially cause vision problems in users.
Eyelash product containing glaucoma drug seized
* Bimatoprost SR: Allergan reported positive topline results from two Phase 3 clinical trials of Bimatoprost SR, a first-in-class sustained-release, biodegradable implant for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Allergan plc (NYSE: AGN)
Akorn (AKRX), up 6% after receiving an approval from the FDA for bimatoprost ophthalmic solution...
Fly Intel: Pre-market Movers
Other medications used after AFR to improve results include 5-fluorouracil, bimatoprost, and poly-L-lactic acid.
Light therapy offers brighter future for scar patients
Prostaglandin analogs/prostamides such as bimatoprost were first approved in 1996 [10] but have become increasingly preferred as first-line options due to their efficacy, safety, and once-daily use [2, 10-14].
A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure

Medical browser ?
Full browser ?